Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

SNY:US

49.9700 USD 1.1700 2.40%

As of 20:04:05 ET on 03/27/2015.

Snapshot for Sanofi (SNY)

Open: 49.5700 Day's Range: 49.3600 - 50.1350 Volume: 1,057,851
Previous Close: 48.8000 52wk Range: 43.5700 - 57.4200 1-Yr Rtn: -0.41%

Stock Chart for SNY

No chart data available.
  • SNY:US 49.9700
  • 1D
  • 1M
  • 1Y
48.8000
Interactive SNY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SNY

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 15.9985
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 2.8650
Est. PEG Ratio 2.5017
Market Cap (M USD) 131,857.58
Shares Outstanding (M) 2,638.74
30 Day Average Volume 1,536,799
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.24%
Cash Dividend (USD) 1.3354
Dividend Ex-Date 05/06/2015
5 Year Dividend Growth 4.83%
Next Earnings Announcement 04/30/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SNY

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for SNY

Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

Serge Daniel WeinbergInterim CEOElias A ZerhouniPres:Global Research & Dev
Jerome ContamineExec VP/CFODavid-Alexandre GrosExec VP/Chief Strategy Ofcr
More Company Profile & Key Executives for SNY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil